Natixis Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $191M | Buy |
1,848,282
+456,036
| +33% | +$40.7M | 0.22% | 96 |
|
|
2026
Q1 | $100M | Buy |
1,392,246
+114,042
| +9% | +$8.79M | 0.14% | 156 |
|
|
2025
Q4 | $101M | Sell |
1,278,204
-55,533
| -4% | -$4.38M | 0.14% | 152 |
|
|
2025
Q3 | $101M | Buy |
1,333,737
+92,377
| +7% | +$6.33M | 0.15% | 155 |
|
|
2025
Q2 | $85.6M | Buy |
1,241,360
+149,921
| +14% | +$9.83M | 0.14% | 168 |
|
|
2025
Q1 | $73.9M | Buy |
1,091,439
+526,240
| +93% | +$31.5M | 0.14% | 165 |
|
|
2024
Q4 | $25.4M | Sell |
565,199
-281,009
| -33% | -$15.8M | 0.05% | 366 |
|
|
2024
Q3 | $53.2M | Buy |
846,208
+170,566
| +25% | +$9.95M | 0.1% | 199 |
|
|
2024
Q2 | $39.9M | Sell |
675,642
-74,630
| -10% | -$4.67M | 0.09% | 229 |
|
|
2024
Q1 | $59.8M | Buy |
750,272
+88,496
| +13% | +$6.76M | 0.14% | 165 |
|
|
2023
Q4 | $52.3M | Buy |
661,776
+154,481
| +30% | +$11M | 0.14% | 169 |
|
|
2023
Q3 | $35.4M | Buy |
507,295
+138,954
| +38% | +$9.85M | 0.11% | 210 |
|
|
2023
Q2 | $25.5M | Sell |
368,341
-109,550
| -23% | -$7.79M | 0.08% | 259 |
|
|
2023
Q1 | $35.5M | Sell |
477,891
-87,565
| -15% | -$7.34M | 0.12% | 198 |
|
|
2022
Q4 | $52.7M | Sell |
565,456
-130,327
| -19% | -$12.6M | 0.2% | 136 |
|
|
2022
Q3 | $66.4M | Buy |
695,783
+145,422
| +26% | +$14.4M | 0.28% | 92 |
|
|
2022
Q2 | $51M | Sell |
550,361
-33,990
| -6% | -$3.32M | 0.22% | 112 |
|
|
2022
Q1 | $59.1M | Buy |
584,351
+14,162
| +2% | +$1.49M | 0.23% | 111 |
|
|
2021
Q4 | $58.8M | Buy |
570,189
+46,905
| +9% | +$4.33M | 0.22% | 109 |
|
|
2021
Q3 | $44.4M | Buy |
523,284
+33,154
| +7% | +$2.78M | 0.18% | 129 |
|
|
2021
Q2 | $40.9M | Buy |
490,130
+18,157
| +4% | +$1.49M | 0.19% | 130 |
|
|
2021
Q1 | $35.5M | Buy |
471,973
+23,242
| +5% | +$1.69M | 0.19% | 138 |
|
|
2020
Q4 | $30.6M | Buy |
448,731
+2,543
| +0.6% | +$165K | 0.18% | 140 |
|
|
2020
Q3 | $26.1M | Sell |
446,188
-39,632
| -8% | -$2.47M | 0.16% | 147 |
|
|
2020
Q2 | $31.6M | Sell |
485,820
-8,688
| -2% | -$547K | 0.21% | 117 |
|
|
2020
Q1 | $29.3M | Buy |
494,508
+35,331
| +8% | +$2.36M | 0.24% | 90 |
|
|
2019
Q4 | $34.1M | Buy |
459,177
+28,707
| +7% | +$2.02M | 0.24% | 86 |
|
|
2019
Q3 | $27.1M | Buy |
430,470
+75,834
| +21% | +$4.49M | 0.22% | 107 |
|
|
2019
Q2 | $19.3M | Buy |
354,636
+130,714
| +58% | +$7.04M | 0.16% | 151 |
|
|
2019
Q1 | $12.1M | Sell |
223,922
-112,319
| -33% | -$6.93M | 0.11% | 214 |
|
|
2018
Q4 | $22M | Buy |
336,241
+43,341
| +15% | +$3.24M | 0.22% | 96 |
|
|
2018
Q3 | $23.1M | Buy |
292,900
+46,090
| +19% | +$3.3M | 0.2% | 99 |
|
|
2018
Q2 | $15.9M | Buy |
246,810
+38,381
| +18% | +$2.53M | 0.15% | 157 |
|
|
2018
Q1 | $13M | Sell |
208,429
-37,194
| -15% | -$2.67M | 0.13% | 174 |
|
|
2017
Q4 | $17.8M | Sell |
245,623
-95,346
| -28% | -$6.93M | 0.18% | 120 |
|
|
2017
Q3 | $27.7M | Buy |
340,969
+23,919
| +8% | +$1.89M | 0.29% | 64 |
|
|
2017
Q2 | $25.5M | Buy |
317,050
+78,665
| +33% | +$6.21M | 0.28% | 68 |
|
|
2017
Q1 | $18.7M | Buy |
238,385
+19,937
| +9% | +$1.59M | 0.21% | 104 |
|
|
2016
Q4 | $17.2M | Buy |
218,448
+46,983
| +27% | +$3.8M | 0.21% | 112 |
|
|
2016
Q3 | $15.3M | Sell |
171,465
-61,829
| -27% | -$5.84M | 0.2% | 116 |
|
|
2016
Q2 | $22.3M | Buy |
233,294
+4,315
| +2% | +$430K | 0.31% | 69 |
|
|
2016
Q1 | $23.8M | Buy |
228,979
+29,565
| +15% | +$2.87M | 0.36% | 54 |
|
|
2015
Q4 | $19.5M | Sell |
199,414
-17,745
| -8% | -$1.74M | 0.32% | 66 |
|
|
2015
Q3 | $21M | Buy |
217,159
+23,283
| +12% | +$2.45M | 0.36% | 51 |
|
|
2015
Q2 | $20.3M | Buy |
193,876
+17,694
| +10% | +$1.81M | 0.35% | 50 |
|
|
2015
Q1 | $18.2M | Sell |
176,182
-4,860
| -3% | -$492K | 0.32% | 53 |
|
|
2014
Q4 | $17.4M | Sell |
181,042
-31,737
| -15% | -$2.8M | 0.33% | 47 |
|
|
2014
Q3 | $16.9M | Buy |
212,779
+31,598
| +17% | +$2.49M | 0.34% | 45 |
|
|
2014
Q2 | $13.7M | Buy |
181,181
+1,930
| +1% | +$146K | 0.2% | 129 |
|
|
2014
Q1 | $13.4M | Buy |
179,251
+27,196
| +18% | +$1.92M | 0.21% | 123 |
|
|
2013
Q4 | $10.9M | Buy |
152,055
+12,803
| +9% | +$823K | 0.18% | 174 |
|
|
2013
Q3 | $7.9M | Buy |
139,252
+3,392
| +2% | +$202K | 0.15% | 233 |
|
|
2013
Q2 | $7.77M | Buy |
+135,860
| New | +$7.87M | 0.15% | 220 |
|
Other funds holding CVS
Natixis Advisors's CVS Position: Q2 2026 in Review
Natixis Advisors increased its CVS Health (CVS) stake by 33% in Q2 2026, buying an estimated $40.7M and bringing the position to 1,848,282 shares worth $191M. The position accounts for 0.22% of the portfolio, ranked #96.
Natixis Advisors first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Natixis Advisors held 1,848,282 shares of CVS Health worth $191M as of Q2 2026.
- Natixis Advisors bought 456,036 CVS Health shares in Q2 2026, an estimated $40.7M.
- CVS Health made up 0.22% of Natixis Advisors's portfolio in Q2 2026, its #96 holding.
- Natixis Advisors first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.